MedTrace Logo

Exercise is Medicine for Patients With CKD

NCT03311763 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2022-02-08

No results posted yet for this study

Summary

The investigators plan to integrate and tailor the existing Exercise is Medicine framework, an evidence-based multi-level intervention program developed by the American Society of Sports Medicine, for the care of patients with advanced chronic kidney disease. In this pilot randomized control trial, investigators will compare the effects and feasibility of two intervention arms designed to start and maintain physical activity in this high-risk population (Group 1: physical activity assessment, brief counseling session + physical activity wearable versus Group 2: Group 1 intervention components + referral to a free, community-based, EIM practitioner led group exercise program).

Conditions

  • Chronic Kidney Disease stage4
  • Chronic Kidney Disease Stage V
  • Physical Activity

Interventions

BEHAVIORAL

EIM Fitness Practitioners

Exercise is Medicine Practitioners will facilitate peer groups that attend twice-weekly exercise classes for 8 weeks, with clinical monitoring and advise regarding increasing physical activity.

BEHAVIORAL

Counseling and wearable device

Brief exercise counseling session and provision of a wearable fitness tracking device to promote physical activity.

Sponsors & Collaborators

  • Emory University

    collaborator OTHER

  • Santa Clara Valley Medical Center

    collaborator OTHER

  • Stanford University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-16
Primary Completion
2020-12-31
Completion
2021-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03311763 on ClinicalTrials.gov